Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?

Bibliographic Details
Main Author:	Martyn E. Caplin
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	EJC Supplements
Subjects:	Cost Cost-effectiveness Neuroendocrine tumours [177Lu]Lu-DOTA-TATE Quality of life PFS
Online Access:	http://www.sciencedirect.com/science/article/pii/S135963492100001X

Internet